Cargando…
Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells
Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from t...
Autores principales: | Kumar, Anupam, Gao, Hui, Xu, Jia, Reuben, James, Yu, Dihua, Mehta, Kapil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110765/ https://www.ncbi.nlm.nih.gov/pubmed/21687668 http://dx.doi.org/10.1371/journal.pone.0020701 |
Ejemplares similares
-
Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
por: Kumar, Anupam, et al.
Publicado: (2010) -
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells
por: Kumar, Anupam, et al.
Publicado: (2012) -
Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells
por: Ayinde, Oluseyi, et al.
Publicado: (2017) -
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011) -
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
por: Agnihotri, Navneet, et al.
Publicado: (2013)